NCT05701007 2026-01-29
Real World Evidence Study on Metastatic Prostate Cancer in the Pirkanmaa Hospital District in Finland
Pfizer
Completed
Clinical Trials
30 trialsNCT06072196 2025-12-31
A Study to Learn About Novel Hormonal Therapies in People With Metastatic Castration-Sensitive Prostate Cancer (mCSPC)
Pfizer
Completed
NCT02821793 2025-07-01
PRIORITY
Institut Bergonié
Completed
NCT04400656 2025-06-18
IP3-PROSPECT
Imperial College London
Completed
NCT06151418 2025-06-04
A Study to Learn About Novel Hormonal Therapies (NHTs) for Metastatic Castration-sensitive Prostate Cancer (mCSPC) in People Who Were in the Armed Forces
Pfizer
Completed
NCT05735652 2025-05-30
An Observational Study of Radiotherapy After Injection of SpaceOAR Hydrogel
Boston Scientific Corporation
Completed
NCT04890314 2025-05-22
PC-CONCEPT
Weill Medical College of Cornell University
Completed
NCT02061345 2023-12-07
PET Imaging in MCI Following ADT for PCa
Imperial College London
Completed
NCT04317690 2022-05-20
Online Trial Examining Validity and Reliability of the Shared Decision Making Process Survey
Massachusetts General Hospital
Completed
NCT03702439 2022-01-27
PROSTAGRAM
Imperial College London
Completed
NCT02957357 2021-10-20
Optimizing the Effectiveness of Routine Post-treatment Surveillance in Prostate Cancer Survivors
Alliance Foundation Trials, LLC.
Completed
NCT02154672 2021-02-09
Prostate Cancer Screening in Men With Germline BRCA2 Mutations
Yale University
Completed
NCT03979079 2021-01-25
PREDYC
Institut Bergonié
Completed
NCT02882178 2021-01-08
CABOBS
Institut Bergonié
Completed
NCT02564120 2020-04-28
North Carolina Prostate Cancer Comparative Effectiveness & Survivorship Study (NC ProCESS)
UNC Lineberger Comprehensive Cancer Center
Completed
NCT01727154 2019-08-19
PRIME
Dendreon
Terminated
NCT01234350 2019-06-25
A Safety Study in Patients With Advanced Prostate Cancer Treated With FIRMAGON
Ferring Pharmaceuticals
Completed
NCT01306890 2019-06-07
PROCEED
Dendreon
Completed
NCT02013180 2019-04-16
Zinc/PSA Ratio as a Novel Biomarker for Prostate Cancer Detection
Bagcilar Training and Research Hospital
Completed
NCT03209492 2019-04-11
Special Drug Use Surveillance of Leuplin PRO for Injection Kit 22.5 mg for "Prostate Cancer"
Takeda
Completed
NCT02443571 2018-12-19
Retrospective Observational Study Investigating Fluciclovine (18F) (FACBC)
Blue Earth Diagnostics
Completed
NCT01386684 2018-12-13
Real Life Evaluation of Lupron in the Management of Prostate Cancer: A Canadian Post Marketing Observational Study
AbbVie
Completed
NCT02340715 2017-10-31
Advanced MRI Sequences for Radiation Therapy Treatment Planning
Medical College of Wisconsin
Completed
NCT02167893 2017-03-29
Leuplin SR 11.25 mg Injection Kit Specified Drug-use Survey "Long-term Use Survey in Prostate Cancer Patients (96 Weeks)"
Takeda
Completed
NCT01444456 2017-03-20
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Amgen
Completed
NCT02233842 2016-09-12
Cognitive Testing of Tobacco Use Measurement Items for Administration With Cancer Patients and Survivors
National Institutes of Health Clinical Center (CC)
Completed
NCT01459653 2016-01-11
Monitor-GCSF
Sandoz
Completed
NCT01320735 2015-07-08
Observational Program to Assess Use of Intermittent Adjuvant Deprivation Therapy With Leuprorelin (Lucrin Depot) in Patients With Advanced Prostate Cancer (PCa) in Russia
AbbVie
Completed
NCT01081873 2012-10-31
Study to Document Treatment Patterns and to Evaluate Leuprolide and Alternative Therapeutic Approaches to the Treatments of Advanced Prostate Cancer
Abbott
Completed
NCT01078545 2012-01-16
LEMON
Abbott
Completed